Pfizer’s COVID-19 vaccine contains mRNA fragments called “truncated mRNA.” This is a serious issue on top of the vaccine’s life-threatening safety events. Stunningly, Pfizer submitted falsified mRNA analytical reports to multiple health authorities. The issue of truncated mRNA led the European Medicines Agency (EMA) to raise a “major objection” before its December 2020 conditional approval of the vaccine. What has happened? How have these issues been considered resolved? This two-part series article will address the matter in depth and examine its potential consequences for human health.
Summary of Key Facts
Pfizer’s COVID-19 vaccine contains truncated mRNA, which the EMA flagged as a reason for its “major objection,” indicating a preclusion of their approval.
Pfizer has not investigated the detrimental outcomes of truncated mRNA in its vaccines.
Pfizer submitted Western blot figures to the Food and Drug Administration (FDA) and the EMA that were digitally generated—not from actual experiments.
There has been an alarming lack of action taken by health authorities on this issue.
Truncated mRNA potentially contributes to multiple vaccine-related injuries, including misfolded spike protein-induced fibrous blood clots, autoimmune disorders, and cancer.
These problems with the Pfizer vaccine could have resulted in drastic product quality variations from batch to batch. This could explain the difference in adverse events experienced by vaccine recipients.
The root cause of such irresponsible conduct by pharma and health authorities is a lack of ethics.